Complex association between body weight and fracture risk in postmenopausal women

Obesity Reviews

Volumn 16, Issue 3, 2015, Pages 225-233

  Mpalaris, V ^a   Anagnostis, P ^a   Goulis, D G ^a   Iakovou, I ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

BMI; Fracture risk; Obesity; Osteoporosis

Indexed keywords

BODY MASS; BODY WEIGHT; BONE DENSITY; COMORBIDITY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FRACTURE; FRAGILITY FRACTURE; HIGH RISK PATIENT; HUMAN; OBESITY; POSTMENOPAUSE; PREDICTION; REVIEW; RISK FACTOR; RISK REDUCTION; AGED; ANALOGS AND DERIVATIVES; COMPLICATION; FRACTURES, BONE; METABOLISM; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PATHOPHYSIOLOGY; PHYSIOLOGY;

25-HYDROXYVITAMIN D; VITAMIN D;

AGED; BODY MASS INDEX; BODY WEIGHT; BONE DENSITY; FEMALE; FRACTURES, BONE; HUMANS; MIDDLE AGED; OBESITY; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS; VITAMIN D;

EID: 84923461628     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12244     Document Type: Review

References (79)

1. Sambrook P, Cooper C. Osteoporosis. Lancet 2006; 367: 2010-2018.
2. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser 1994; 843: 1-129.
3. World Health Organization. WHO Scientific Group on the assessment of osteoporosis at primary health care level. Summary Meeting Report Brussels, Belgium, 2004.
4. Pasco JA, Seeman E, Henry MJ, Merriman EN, Nicholson GC, Kotowicz MA. The population burden of fractures originates in women with osteopenia, not osteoporosis. Osteoporos Int 2006; 17: 1404-1409.
5. Kanis JA, Borgstrom F, De Laet C etal. Assessment of fracture risk. Osteoporos Int 2005; 16: 581-589.
6. Ravn P, Cizza G, Bjarnason NH etal. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group. J Bone Miner Res 1999; 14: 1622-1627.
7. Robbins J, Schott AM, Azari R, Kronmal R. Body mass index is not a good predictor of bone density: results from WHI, CHS, and EPIDOS. J Clin Densitom 2006; 9: 329-334.
8. Marcus R, Greendale G, Blunt BA etal. Correlates of bone mineral density in the postmenopausal estrogen/progestin interventions trial. J Bone Miner Res 1994; 9: 1467-1476.
9. Wapniarz M, Lehmann R, Reincke M, Schonau E, Klein K, Allolio B. Determinants of radial bone density as measured by pQCT in pre- and postmenopausal women - the role of bone size. J Bone Miner Res 1997; 12: 248-254.
10. Vico L, Prallet B, Chappard D, Pallot-Prades B, Pupier R, Alexandre C. Contributions of chronological age, age at menarche and menopause and of anthropometric parameters to axial and peripheral bone densities. Osteoporos Int 1992; 2: 153-158.
11. Hyldstrup L, Andersen T, McNair P, Breum L, Transbol I. Bone metabolism in obesity - changes related to severe overweight and dietary weight reduction. Acta Endocrinol 1993; 129: 393-398.
12. Ricci TA, Heymsfield SB, Pierson RN, Stahl T, Chowdhury HA, Shapses SA. Moderate energy restriction increases bone resorption in obese postmenopausal women. Am J Clin Nutr 2001; 73: 347-352.
13. Prieto-Alhambra D, Premaor MO, FinaAvilés F etal. The association between fracture and obesity is site-dependent: a population-based study in postmenopausal women. J Bone Miner Res 2012; 27: 294-300.
14. Gnudi S, Sitta E, Lisi L. Relationship of body mass index with main limb fragility fractures in postmenopausal women. J Bone Miner Metab 2009; 27: 479-484.
15. Compston JE, Watts NB, Chapurlat R etal. Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med 2011; 124: 1043-1050.
16. Williams AR, Weiss NS, Ure CL, Ballard J, Daling JR. Effect of weight, smoking, and estrogen use on the risk of hip and forearm fractures in postmenopausal women. Obstet Gynecol 1982; 60: 695-699.
17. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Exercise and other factors in the prevention of hip fracture: the Leisure World study. Epidemiology 1991; 2: 16-25.
18. DiPietro L, Welch GA, Davis DR, Drane JW, Macera CA. Body mass and risk of hip fracture among a national cohort of postmenopausal white women: a reanalysis. Obes Res 1993; 1: 357-363.
19. Turner LW, Faile PA, Tomlinson R Jr. Osteoporosis diagnosis and fracture. Orthop Nurs 1999; 18: 21-27.
20. Young Y, Myers AH, Provenzano G. Factors associated with time to first hip fracture. J Aging Health 2001; 13: 511-526.
21. Cummings SR, Nevitt MC, Browner WS etal. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995; 332: 767-773.
22. Ensrud KE, Lipschutz RC, Cauley JA etal. Body size and hip fracture risk in older women - a prospective study. Am J Med 1997; 103: 274-280.
23. Johnell O, O'Neill T, Elsenberg D, Kanis J, Cooper C, Silman AJ. Anthropometric measurements and vertebral deformities. European Vertebral Osteoporosis Study (EVOS) Group. Am J Epidemiol 1997; 15: 287-293.
24. Joakimsen RM, Fønnebø V, Magnus JH, Tollan A, Søgaard AJ. The Tromsø Study: body height, body mass index and fractures. Osteoporos Int 1998; 8: 436-442.
25. Honkanen RJ, Honkanen K, Kröger H, Alhava E, Tuppurainen M, Saarikoski S. Risk factors for perimenopausal distal forearm fracture. Osteoporos Int 2000; 11: 265-270.
26. van der Voort DJ, Geusens PP, Dinant GJ. Risk factors for osteoporosis related to their outcome: fractures. Osteoporos Int 2001; 12: 630-638.
27. Pirro M, Fabbriciani G, Leli C etal. High weight or body mass index increase the risk of vertebral fractures in postmenopausal osteoporotic women. J Bone Miner Metab 2010; 28: 88-93.
28. Bergkvist D, Hekmat K, Svensson T, Dahlberg L. Obesity in orthopedic patients. Surg Obes Relat Dis 2009; 5: 670-672.
29. De Laet C, Kanis JA, Odén A etal. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 2005; 16: 1330-1338.
30. Johansson H, Kanis JA, Odén A etal. A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res 2014; 29: 223-233.
31. Paulis WD, Silva S, Koes BW, van Middelkoop M. Overweight and obesity are associated with musculoskeletal complaints as early as childhood: a systematic review. Obes Rev 2014; 15: 52-67.
32. Reid IR. Relationships between fat and bone. Osteoporos Int 2008; 19: 595-606.
33. Premaor MO, Ensrud K, Lui L etal. Risk factors for nonvertebral fracture in obese older women. J Clin Endocrinol Metab 2011; 96: 2414-2421.
34. Corbeil P, Simoneau M, Rancourt D, Tremblay A, Teasdale N. Increased risk for falling associated with obesity: mathematical modeling of postural control. IEEE Trans Neural Syst Rehabil Eng 2001; 9: 126-136.
35. Mignardot JB, Olivier I, Promayon E, Nougier V. Obesity impact on the attentional cost for controlling posture. PLoS ONE 2010; 5: e14387.
36. Bouxsein ML, Szulc P, Munoz F, Thrall E, Sornay-Rendu E, Delmas PD. Contribution of trochanteric soft tissues to fall force estimates, the factor of risk, and prediction of hip fracture risk. J Bone Miner Res 2007; 22: 825-831.
37. Stenholm S, Harris TB, Rantanen T etal. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 2008; 11: 693-700.
38. Lang T, Cauley JA, Tylavsky F etal. Computed tomographic measurements of thigh muscle cross-sectional area and attenuation coefficient predict hip fracture: the health, aging, and body composition study. J Bone Miner Res 2010; 25: 513-519.
39. Fjeldstad C, Fjeldstad AS, Acree LS, Nickel KJ, Gardner AW. The influence of obesity on falls and quality of life. Dyn Med 2008; 7: 4.
40. Bolland MJ, Grey AB, Gamble GD, Reid IR. Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab 2005; 90: 1525-1530.
41. Bolland MJ, Grey AB, Ames RW, Horne AM, Gamble GD, Reid IR. Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women. Bone 2006; 38: 317-321.
42. Sukumar D, Schlussel Y, Riedt CS, Gordon C, Stahl T, Shapses SA. Obesity alters cortical and trabecular bone density and geometry in women. Osteoporos Int 2011; 22: 635-645.
43. Tzotzas T, Papadopoulou FG, Tziomalos K etal. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab 2010; 95: 4251-4257.
44. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-693.
45. Eastell R, Black DM, Boonen S etal. Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. J Clin Endocrinol Metab 2009; 94: 3215-3225.
46. Nielson CM, Srikanth P, Orwoll ES. Obesity and fracture in men and women: an epidemiologic perspective. J Bone Miner Res 2012; 27: 1-10.
47. Athyros VG, Tziomalos K, Karagiannis A, Anagnostis P, Mikhailidis DP. Should adipokines be considered in the choice of the treatment of obesity-related health problems? Curr Drug Targets 2010; 11: 122-135.
48. Cornish J, Callon KE, Bava U etal. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 2002; 175: 405-415.
49. Thomas T. The complex effects of leptin on bone metabolism through multiple pathways. Curr Opin Pharmacol 2004; 4: 295-300.
50. Anagnostis P, Vakalopoulou S, Charizopoulou M etal. Is there any association between leptin levels and bone mineral density in haemophiliac men. Arch Med Sci 2013; 9: 459-465.
51. Ushiroyama T, Ikeda A, Hosotani T, Higashiyama T, Ueki M. Inverse correlation between serum leptin concentration and vertebral bone density in postmenopausal women. Gynecol Endocrinol 2003; 17: 31-36.
52. Yamauchi M, Sugimoto T, Yamaguchi T etal. Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol (Oxf) 2001; 55: 341-347.
53. Sabour H, Javidan AN, Latifi S etal. Relationship between leptin and adiponectin concentrations in plasma and femoral and spinal bone mineraldensity in spinal cord injured individuals. Spine J 2014; doi: 10.1016/j.spinee.2014.06.009 [Epub ahead of print].
54. Oshima K, Nampei A, Matsuda M etal. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 2005; 331: 520-526.
55. Berner HS, Lyngstadaas SP, Spahr A etal. Adiponectin and its receptors are expressed in bone-forming cells. Bone 2004; 35: 842-849.
56. Shinoda Y, Yamaguchi M, Ogata N etal. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem 2006; 99: 196-208.
57. Kontogianni MD, Dafni UG, Routsias JG, Skopouli FN. Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J Bone Miner Res 2004; 19: 546-551.
58. Jürimäe J, Jürimäe T, Leppik A, Kums T. The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women. J Bone Miner Metab 2008; 26: 618-623.
59. Biver E, Salliot C, Combescure C etal. Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011; 96: 2703-2713.
60. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 2009; 94: 2692-2701.
61. Anagnostis P, Katsiki N, Adamidou F etal. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders? Metabolism 2013; 62: 21-33.
62. Cooper MS, Walker EA, Bland R, Fraser WD, Hewison M, Stewart PM. Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone. Bone 2000; 27: 375-381.
63. Zhao LJ, Jiang H, Papasian CJ etal. Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res 2008; 23: 17-29.
64. Hwang JY, Lee SH, Kim GS etal. HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without a clinically apparent hypercortisolemia. Bone 2009; 45: 1098-1103.
65. Wu L, Qi H, Zhong Y etal. 11β-hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction. Endocr J 2013; 60: 1047-1058.
66. Park JS, Bae SJ, Choi SW etal. A novel 11β-HSD1 inhibitor improves diabesity and osteoblast differentiation. J Mol Endocrinol 2014; 52: 191-202.
67. Reid IR, Ames R, Evans MC etal. Determinants of total body and regional bone mineral density in normal postmenopausal women - a key role for fat mass. J Clin Endocrinol Metab 1992; 75: 45-51.
68. Arimatsu M, Kitano T, Kitano N, Futatsuka M. Correlation between bone mineral density and body composition in Japanese females aged 18-40 years with low forearm bone mineral density. Environ Health Prev Med 2009; 14: 46-51.
69. Douchi T, Kuwahata R, Matsuo T, Uto H, Oki T, Nagata Y. Relative contribution of lean and fat mass component to bone mineral density in males. J Bone Miner Metab 2003; 21: 17-21.
70. Søgaard AJ, Holvik K, Omsland TK etal. Abdominal obesity increases the risk of hip fracture. A population-based study of 43, 000 women and men aged 60-79 years followed for 8 years. Cohort of Norway. J Intern Med 2014; doi: 10.1111/joim.12230 [Epub ahead of print].
71. Yang S, Nguyen ND, Center JR, Eisman JA, Nguyen TV. Association between abdominal obesity and fracture risk: a prospective study. J Clin Endocrinol Metab 2013; 98: 2478-2483.
72. Nguyen ND, Pongchaiyakul C, Center JR, Eisman JA, Nguyen TV. Abdominal fat and hip fracture risk in the elderly: the Dubbo Osteoporosis Epidemiology Study. BMC Musculoskelet Disord 2005; 6: 11.
73. Dede AD, Tournis S, Dontas I, Trovas G. Type 2 diabetes mellitus and fracture risk. Metabolism 2014; 63: 1480-1490.
74. Montagnani A, Gonnelli S, Alessandri M, Nuti R. Osteoporosis and risk of fracture in patients with diabetes: an update. Aging Clin Exp Res 2011; 23: 84-90.
75. Anagnostis P, Karagiannis A, Kakafika AI, Tziomalos K, Athyros VG, Mikhailidis DP. Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? Osteoporos Int 2009; 20: 197-207.
76. Leslie WD, Morin SN, Lix LM, Majumdar SR. Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture? Osteoporos Int 2014; 25: 2817-2824.
77. Giangregorio LM, Leslie WD, Lix LM etal. FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res 2012; 27: 301-308.
78. Zhu ZN, Jiang YF, Ding T. Risk of fracture with thiazolidinediones: an updated meta-analysis of randomized clinical trials. Bone 2014; 68C: 115-123.
79. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 2004; 3: 379-389.